A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

GSK Investigational Site, Washington D.C.

GSK Investigational Site, Baltimore

GSK Investigational Site, Winchester

GSK Investigational Site, Richmond

GSK Investigational Site, Norfolk

GSK Investigational Site, Winston-Salem

GSK Investigational Site, Salisbury

GSK Investigational Site, Hickory

GSK Investigational Site, Statesville

GSK Investigational Site, Mt. Pleasant

GSK Investigational Site, Duhwoody

GSK Investigational Site, Jacksonville

GSK Investigational Site, Jacksonville

GSK Investigational Site, Longwood

GSK Investigational Site, Hollywood

GSK Investigational Site, Coral Gables

GSK Investigational Site, Pinellas Park

GSK Investigational Site, Bristol

GSK Investigational Site, Louisville

GSK Investigational Site, Cincinnati

GSK Investigational Site, Cincinnati

GSK Investigational Site, Bloomington

GSK Investigational Site, Chicago

GSK Investigational Site, Wentzville

GSK Investigational Site, St Louis

GSK Investigational Site, Kansas City

GSK Investigational Site, Oklahoma City

GSK Investigational Site, San Antonio

GSK Investigational Site, Spring Valley

GSK Investigational Site, Auburn

GSK Investigational Site, Scarborough

GSK Investigational Site, Cumberland